Etiometry Closes the Gap in ARDS/PARDS Detection
News and Press Releases
In the winter issue of Respiratory Therapy, Jo’el Barr, Clinical Development Specialist at Etiometry, shares insights on the deployment of our PARDS pathway in two top U.S. children’s hospitals. The article highlights how Etiometry’s technology is empowering clinicians to recognize and manage Pediatric ARDS more effectively, driving better outcomes for critically ill children.
Related
Multicenter Study Demonstrates 29% Reduction in Vasoactive Infusion Time with Use of Etiometry’s AI Powered Clinical Intelligence Platform
Study published in Critical Care Medicine highlights impact of IDO2-informed decision support on reducing postoperative support duration June 17, 2025 – BOSTON – A newly published multicenter clinical trial in Critical Care Medicine shows that use of Etiometry’s Clinical Intelligence Platform—specifically its Inadequate Delivery of Oxygen (IDO2) Index—was associated with a significant reduction in the […]
Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery
Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]
Health Tech: Shane Cooke Of Etiometry On How Their Technology Can Make An Important Impact On Our Overall Wellness
An Interview With David Leichner published by Authority Magazine From discussing the five things every health tech founder should know, to the real-world impact of Etiometry’s technology in the ICU, this piece offers a compelling look into the mission driving our team forward every day. Read the full interview HERE